Alliance Wealth Advisors (Utah)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
CAM
CCM
PM
MAP
IP
WC
MNBTD
CPC
Alliance Wealth Advisors (Utah)'s LGND Position: Q2 2026 in Review
Alliance Wealth Advisors (Utah) opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 1,772 shares worth $560K. The stake represents 0.11% of the portfolio and ranks #120 among its holdings.
71 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Alliance Wealth Advisors (Utah) held 1,772 shares of Ligand Pharmaceuticals worth $560K as of Q2 2026.
- Ligand Pharmaceuticals was a new Alliance Wealth Advisors (Utah) position in Q2 2026.
- Ligand Pharmaceuticals made up 0.11% of Alliance Wealth Advisors (Utah)'s portfolio in Q2 2026, its #120 holding.
- 71 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.